AlphaQuest LLC Trims Stock Position in Sabra Healthcare REIT, Inc. $SBRA

Key Points

• AlphaQuest LLC has reduced its holdings in Sabra Healthcare REIT, Inc. by 55.9%, selling 19,787 shares and leaving them with 15,584 shares valued at approximately $272,000.
• Sabra Healthcare REIT reported $0.38 earnings per share for the last quarter, surpassing analysts' expectations, and also announced a dividend of $0.30 per share, yielding 6.2%.
• Analysts have increased their price targets for Sabra Healthcare REIT, with BMO Capital raising it from $19.00 to $22.00 and Wells Fargo from $20.00 to $21.00, reflecting a positive outlook for the stock.

AlphaQuest LLC lessened its holdings in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 55.9% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 15,584 shares of the real estate investment trust's stock after selling 19,787 shares during the period. AlphaQuest LLC's holdings in Sabra Healthcare REIT were worth $272,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in SBRA. Nuveen LLC acquired a new stake in shares of Sabra Healthcare REIT during the 1st quarter worth approximately $61,791,000. Jefferies Financial Group Inc. boosted its position in shares of Sabra Healthcare REIT by 7,196.8% during the 1st quarter. Jefferies Financial Group Inc. now owns 1,466,000 shares of the real estate investment trust's stock worth $25,611,000 after acquiring an additional 1,445,909 shares in the last quarter. Northern Trust Corp boosted its position in shares of Sabra Healthcare REIT by 27.7% during the 4th quarter. Northern Trust Corp now owns 4,169,385 shares of the real estate investment trust's stock worth $72,214,000 after acquiring an additional 905,466 shares in the last quarter. Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in shares of Sabra Healthcare REIT during the 4th quarter worth approximately $14,241,000. Finally, Wellington Management Group LLP lifted its stake in Sabra Healthcare REIT by 33.7% in the 4th quarter. Wellington Management Group LLP now owns 3,205,042 shares of the real estate investment trust's stock valued at $55,511,000 after purchasing an additional 808,207 shares during the last quarter. Institutional investors and hedge funds own 99.40% of the company's stock.

Wall Street Analysts Forecast Growth

SBRA has been the subject of several research reports. Wells Fargo & Company increased their price objective on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an "overweight" rating in a research note on Wednesday. Scotiabank raised their price target on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a "sector perform" rating in a research note on Monday, June 23rd. BMO Capital Markets raised their price target on shares of Sabra Healthcare REIT from $19.00 to $22.00 and gave the company a "market perform" rating in a research note on Monday, August 25th. Finally, JMP Securities lifted their target price on shares of Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a "market outperform" rating in a research note on Wednesday, August 6th. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $20.43.

Sabra Healthcare REIT Stock Down 1.0%

Shares of NASDAQ SBRA traded down $0.20 during mid-day trading on Friday, reaching $19.11. 2,586,825 shares of the company's stock traded hands, compared to its average volume of 2,738,903. The stock has a market cap of $4.58 billion, a P/E ratio of 25.15, a PEG ratio of 1.52 and a beta of 0.88. The business has a 50-day simple moving average of $18.56 and a 200 day simple moving average of $17.80. Sabra Healthcare REIT, Inc. has a 1-year low of $15.60 and a 1-year high of $20.03. The company has a debt-to-equity ratio of 0.91, a current ratio of 4.80 and a quick ratio of 4.80.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last issued its quarterly earnings data on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.36 by $0.02. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. The firm had revenue of $189.15 million during the quarter, compared to analysts' expectations of $185.64 million. During the same period last year, the company earned $0.36 earnings per share. The business's revenue was up 7.4% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. On average, analysts expect that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, August 29th. Investors of record on Friday, August 15th were given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.3%. The ex-dividend date of this dividend was Friday, August 15th. Sabra Healthcare REIT's dividend payout ratio (DPR) is presently 157.89%.

Sabra Healthcare REIT Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.